Benefit Plans	6 Months Ended
Apr. 30, 2017
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Benefit Plans	Note 14. Benefit Plans The Company has 2006 and 2010 Equity Incentive Plans (collectively, the “Equity Plans”). In April 2017, the number of shares of common stock reserved for issuance under the Equity Plans was increased to 4.5 million shares by vote of a majority of the Company’s security holders. As of April 30, 2017 there were 0.2 million shares available for grant. As of April 30, 2017, equity awards outstanding consisted of incentive stock options, nonstatutory stock options, restricted stock awards (“RSAs”) and restricted stock units (“RSUs”). Restricted Stock Awards and Units Total RSA and RSU’s granted during the six months ended April 30, 2017 total 2.5 million. RSA and RSU expense is based on the fair value of the award at the date of grant and is amortized over the vesting period which is either over 3 or 4 years. Total RSA and RSU’s outstanding as of April 30, 2017 is 3.1 million shares. Stock Awards During the six months ended April 30, 2017, the Company awarded 86,000 shares of fully vested, unrestricted common stock to the independent members of our board of directors as a component of board of director compensation which resulted in recognition of $0.1 million of expense.

Benefit Plans

6 Months Ended

Apr. 30, 2017

Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]

Note 14. Benefit Plans

The Company has 2006 and 2010 Equity Incentive Plans (collectively, the “Equity Plans”). In April 2017, the number of shares of common stock reserved for issuance under the Equity Plans was increased to 4.5 million shares by vote of a majority of the Company’s security holders. As of April 30, 2017 there were 0.2 million shares available for grant. As of April 30, 2017, equity awards outstanding consisted of incentive stock options, nonstatutory stock options, restricted stock awards (“RSAs”) and restricted stock units (“RSUs”).

Restricted Stock Awards and Units

Total RSA and RSU’s granted during the six months ended April 30, 2017 total 2.5 million. RSA and RSU expense is based on the fair value of the award at the date of grant and is amortized over the vesting period which is either over 3 or 4 years. Total RSA and RSU’s outstanding as of April 30, 2017 is 3.1 million shares.

Stock Awards

During the six months ended April 30, 2017, the Company awarded 86,000 shares of fully vested, unrestricted common stock to the independent members of our board of directors as a component of board of director compensation which resulted in recognition of $0.1 million of expense.